NCT06109493Recruiting
Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 23 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of patients with chronic kidney disease.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 104 (estimated)
- First submitted
- 25 Oct 2023
- Start date
- 1 Nov 2023
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Universidad Europea de Madrid
- Diseases
- Chronic kidney disease
- NCT number
- NCT06109493
What you commit to
- Study type: Interventional
- Planned participants: 104
- From 1 Nov 2023 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Antidepressant drugs consume
- Receiving other psychological treatment
Other illness
- Diagnosis of severe or chronic mental disorder, mental retardation and cognitive impairment, or disabling illness.
- Patients who are in the Advanced Chronic Kidney Disease Unit
Other
- Insufficient understanding of Spanish.
Who the study is looking for
- Patients with chronic kidney disease on haemodialysis
- Older than 18 years-old
- At least 3 months on haemodialysis
- HADS Global Scale Score ≥14
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fundación Renal Iñigo Alvarez de Toledo Coordinator of this site? Confirm its status | Madrid | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.